’ Meeting No.1/2018 held on 21 February 2018.There is the approval of investment for the new Hospital at Suratthani under the name of “Wattanapat Samui Hospital” (Wattanapat Samui Hospital Project) which is
consider the credit risk of its customers, resulting in drop in revenue in 2017. However, Thailand is currently well-position to be a medical hub of Asia, new hospitals are planned to build to serve
, Hua Hin Branch, Sriracha Branch, Phra Nakorn Sri Ayutthaya Branch and Hat Yai Branch (which started to operate since 6 April 2017). The Company plans to open at least three new outlets by 2018. Industry
increase of a number of 100 million shares by right offering (RO) to existing shareholders at a proportion of 3.89996876 new ordinary shares/1 held share and also 100 million shares by private placement for
percent compared to the same quarter of the previous year because of the new product has been launched for both seaweed snack product and other category including the recovery of domestic market and tourist
February 2018.There is the approval of investment for the new Hospital at Suratthani under the name of “Wattanapat Samui Hospital” (Wattanapat Samui Hospital Project) which is involved in the transaction to
payment date was on 25 May 2018. June The Company’s warrants (RML-W4) reached its due date of the last exercise on 14 June 2018. 520 new shares were derived from exercised of warrants in this period. July 1
31.08 3.15 -30.59 -27.49 -41.57 14.08/1 -33.87 Revenues from medical services of the previous branches and new branches: Revenues from medical services For the 3 months For the 9 months Change between YoY